Two years into its OTC drug quality-control remediation program, Johnson & Johnson has received an FDA warning letter concerning the firm’s handling of consumer complaints for consumer products regulated as devices.
The May 22 letter cites violations related to K-Y brand moisturizers, O.B. tampons and Reach dental floss and suggests that...